miglitol
Selected indexed studies
- Miglitol. (, 2012) [PMID:31643214]
- Miglitol. (, 2006) [PMID:30000337]
- Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus. (Drugs, 2000) [PMID:10776834]
_Worker-drafted node — pending editorial review._
Connections
miglitol is a side effect of
Sources
- Miglitol. (2012) pubmed
- Miglitol. (2006) pubmed
- Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus. (2000) pubmed
- Review: Miglitol has potential as a therapeutic drug against obesity. (2015) pubmed
- Miglitol, a new alpha-glucosidase inhibitor. (1999) pubmed
- Miglitol: assessment of its role in the treatment of patients with diabetes mellitus. (2000) pubmed
- Miglitol, an Oral Antidiabetic Drug, Downregulates Melanogenesis in B16F10 Melanoma Cells through the PKA, MAPK, and GSK3β/β-Catenin Signaling Pathways. (2022) pubmed
- N-Hydroxyethyl-1-Deoxynojirimycin (Miglitol) Restores the Counterregulatory Response to Hypoglycemia Following Antecedent Hypoglycemia. (2022) pubmed
- Herbal Medicines for Diabetes Management and its Secondary Complications. (2021) pubmed
- Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis. (2015) pubmed